Genetic variations of NR2A1 in Asian populations: Implications in pharmacogenetics studies

Drug Metabolism and Pharmacokinetics

Volumn 28, Issue 3, 2013, Pages 278-288

  Chew, Sin Chi ^a,b   Liu Lim, Joanne Siok ^a,b   Lee, Edmund Jd ^b   Chowbay, Balram ^a,c  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Asians; HNF4 ; In silico prediction; NR2A1; Pharmacogenetics; Polymorphisms; Tag SNPs

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 4ALPHA; TRANSCRIPTION FACTOR;

ADULT; ALLELE; ARTICLE; ASIAN; BINDING SITE; CHINESE; COMPUTER ANALYSIS; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; HUMAN; INDIAN; MALAY; MALE; NORMAL HUMAN; NR2A1 GENE; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84879400118     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-12-SH-114     Document Type: Article

References (32)

1. Sladek, F. M., Zhong, W. M., Lai, E. and Darnell, J. E.: Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev., 4: 2353-2365 (1990).
2. Stoffel, M. and Duncan, S.: The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. Proc. Natl. Acad. Sci. USA, 94: 13209-13214 (1997).
3. Duncan, S. A., Manova, K., Chen, W. S., Hoodless, P., Weinstein, D. C., Bachvarova, R. F. and Darnell, J. E.: Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. Proc. Natl. Acad. Sci. USA, 91: 7598-7602 (1994).
4. Urquhart, B. L., Tirona, R. G. and Kim, R. B.: Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J. Clin. Pharmacol., 47: 566-578 (2007).
5. Torres-Padilla, M. E., Fougère-Deschatrette, C. and Weiss, M. C.: Expression of HNF4alpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3A end splicing. Mech. Dev., 109: 183-193 (2001).
6. Nakhei, H., Lingott, A., Lemm, I. and Ryffel, G.: An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types. Nucleic Acids Res., 26: 497-504 (1998).
7. Thomas, H., Jaschkowitz, K., Bulman, M., Frayling, T. M., Mitchell, S. M., Roosen, S., Lingott-Frieg, A., Tack, C. J., Ellard, S., Ryffel, G. U. and Hattersley, A. T.: A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum. Mol. Genet., 10: 2089-2097 (2001).
8. Ruse, M. D., Privalsky, M. L. and Sladek, F. M.: Competitive Cofactor Recruitment by Orphan Receptor Hepatocyte Nuclear Factor 4alpha1: Modulation by the F Domain. Mol. Cell. Biol., 22: 1626-1638 (2002).
9. Wisely, G. B., Miller, A. B., Davis, R. G., Thornquest, A. D., Johnson, R., Spitzer, T., Sefler, A., Shearer, B., Moore, J. T., Miller, A. B., Willson, T. M. and Williams, S. P.: Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure, 10: 1225-1234 (2002).
10. Jiang, G., Nepomuceno, L., Hopkins, K. and Sladek, F.: Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol. Cell. Biol., 15: 5131-5143 (1995).
11. Tirona, R. G., Lee, W., Leake, B. F., Lan, L. B., Cline, C. B., Lamba, V., Parviz, F., Duncan, S. A., Inoue, Y., Gonzalez, F. J., Schuetz, E. G. and Kim, R. B.: The orphan nuclear receptor HNF4alpha determines PXRand CAR-mediated xenobiotic induction of CYP3A4. Nat. Med., 9: 220-224 (2003).
12. Chen, Y., Kissling, G., Negishi, M. and Goldstein, J. A.: The nuclear receptors constitutive androstane receptor and pregnane X receptor crosstalk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter. J. Pharmacol. Exp. Ther., 314: 1125-1133 (2005).
13. Ferguson, S. S., Chen, Y., LeCluyse, E. L., Negishi, M. and Goldstein, J. A.: Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha. Mol. Pharmacol., 68: 747-757 (2005).
14. Cairns, W., Smith, C. A., McLaren, A. W. and Wolf, C. R.: Characterization of the human cytochrome P4502D6 promoter. A potential role for antagonistic interactions between members of the nuclear receptor family. J. Biol. Chem., 271: 25269-25276 (1996).
15. Pitarque, M., Rodríguez-Antona, C., Oscarson, M. and Ingelman-Sundberg, M.: Transcriptional regulation of the human CYP2A6 gene. J. Pharmacol. Exp. Ther., 313: 814-822 (2005).
16. Li, T. and Chiang, J. Y. L.: Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression. Drug Metab. Dispos., 34: 756-764 (2006).
17. Kamiyama, Y., Matsubara, T., Yoshinari, K., Nagata, K., Kamimura, H. and Yamazoe, Y.: Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA. Drug Metab. Pharmacokinet., 22: 287-298 (2007).
18. Wortham, M., Czerwinski, M., He, L., Parkinson, A. and Wan, Y. J. Y.: Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab. Dispos., 35: 1700-1710 (2007).
19. Kuo, C. J., Conley, P. B., Chen, L., Sladek, F. M., Darnell, J. E. and Crabtree, G. R.: A transcriptional hierarchy involved in mammalian celltype specification. Nature, 355: 457-461 (1992).
20. Pascussi, J. M., Robert, A., Moreau, A., Ramos, J., Bioulac-Sage, P., Navarro, F., Blanc, P., Assenat, E., Maurel, P. and Vilarem, M. J.: Differential regulation of constitutive androstane receptor expression by hepatocyte nuclear factor4alpha isoforms. Hepatology, 45: 1146-1153 (2007).
21. Fukushima-Uesaka, H., Saito, Y., Maekawa, K., Saeki, M., Kamatani, N., Kajio, H., Kuzuya, N., Yasuda, K. and Sawada, J.: Novel genetic variations and haplotypes of hepatocyte nuclear factor 4alpha (HNF4A) found in Japanese type II diabetic patients. Drug Metab. Pharmacokinet., 21: 337-346 (2006).
22. Barrett, J. C., Fry, B., Maller, J. and Daly, M. J.: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21: 263-265 (2005).
23. Xu, Z., Kaplan, N. L. and Taylor, J. A.: TAGster: efficient selection of LD tag SNPs in single or multiple populations. Bioinformatics, 23: 3254-3255 (2007).
24. Yuan, H. Y., Chiou, J. J., Tseng, W. H., Liu, C. H., Liu, C. K., Lin, Y. J., Wang, H. H., Yao, A., Chen, Y. T. and Hsu, C. N.: FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res., 34: W635-W641 (2006).
25. Kumar, P., Henikoff, S. and Ng, P. C.: Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc., 4: 1073-1081 (2009).
26. Ramamoorthy, A., Li, L., Gaedigk, A., Bradford, L. D., Benson, E. A., Flockhart, D. A. and Skaar, T. C.: In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4¡ expression. Drug Metab. Dispos., 40: 726-733 (2012).
27. Wirsing, A., Senkel, S., Klein-Hitpass, L., Ryffel, G. U. and Tian, B.: A systematic analysis of the 3AUTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites. PLoS ONE, 6: e27438 (2011).
28. Takagi, S., Nakajima, M., Kida, K., Yamaura, Y., Fukami, T. and Yokoi, T.: MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle. J. Biol. Chem., 285: 4415-4422 (2010).
29. Jiang, G. and Sladek, F. M.: The DNA binding domain of hepatocyte nuclear factor 4 mediates cooperative, specific binding to DNA and heterodimerization with the retinoid X receptor alpha. J. Biol. Chem., 272: 1218-1225 (1997).
30. Zhu, Q., Yamagata, K., Miura, A., Shihara, N., Horikawa, Y., Takeda, J., Miyagawa, J. and Matsuzawa, Y.: T130I mutation in HNF-4alpha gene is a loss-of-function mutation in hepatocytes and is associated with lateonset Type 2 diabetes mellitus in Japanese subjects. Diabetologia, 46: 567-573 (2003).
31. Møller, A., Urhammer, S. and Dalgaard, L.: Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4¡ in Caucasians with matu-rity onset NIDDM. Diabetologia, 40: 980-983 (1997).
32. Mishra, P. J., Humeniuk, R., Longo-Sorbello, G. S. A., Banerjee, D. and Bertino, J. R.: A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc. Natl. Acad. Sci. USA, 104: 13513-13518 (2007).